Search Results 1151-1160 of 16983 for pharmacogenetics
This is a Phase 1 dose-escalation study of PRT3789, a SMARCA2 degrader, in participants with advanced or metastatic solid tumors with loss of SMARCA4 due to ...
This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).
Ali A, Bosse RC, Doonan BP, Narayan P, Jester GA, Delaune JD, Barish JL, Welniak SL, Norton HF, Heldermon CD. Ommaya Reservoir Related Complications: A Single ...
About this study. To assess the effectiveness of daily TransCon PTH on serum and calcium levels and active vitamin D and calcium doses at 4 weeks of ...
This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
About this study. The purpose pf this study is to identify the individual contribution of the pronator quadratus and pronator teres during various forearm ...
Latest stories · Mayo Clinic uses genomic testing broadly for rare diseases, improves patient care featured image · How preeclampsia accelerates aging in women ...
GBD 2023 Asia Chronic Respiratory Disease Collaborators. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.